Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    ADL.MC Net Margin

    As of 2025-07-06, the Net Margin of ADL Bionatur Solutions SA (ADL.MC) is -97.7%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    ADL.MC Net Margin - Historical Value
    DateValue
    2021-12-31 -97.7%
    2020-12-31 -340.9%
    2019-12-31 -473.4%
    2018-12-31 -72.8%
    2017-12-31 -3.1%
    2016-12-31 -86.6%
    2015-12-31 -23.4%
    2014-12-31 63.5%
    2013-12-31 54%
    2012-12-31 -77.3%
    ADL.MC Net Margin - Peers Comparison
    TickerNameValue
    ACTI.STActive Biotech AB publ-479.5%
    ADOC.PAAdocia SA-100%
    AEGIR.STAegirbio AB-64887%
    ALGEN.PAGenoway SA8.3%
    ALLR.STAllarity Therapeutics A/S-16473.8%
    ALNOX.PANoxxon Pharma NV-12954.2%
    ALONC.PAOncodesign SA-0.9%
    ALPAT.PAPlant Advanced Technologies PAT SA48.5%
    ATORX.STAlligator Bioscience AB-404.9%
    BIO.MCBiosearch SA5.9%
    BLR.WABlirt SA17.1%
    EGTX.STEgetis Therapeutics AB (publ)-745.1%
    GEN.WAGenomed SA4.8%
    GNFT.PAGenfit SA2.1%
    GRF.MCGrifols SA2.2%
    GUARD.STGuard Therapeutics International AB (publ)-42397%
    GV.PAGenomic Vision SA-661.8%
    IKM.MC1nkemia IUCT Group SA-1188.4%
    KURN.SWKuros Biosciences AG-7%
    LIDDS.STLidds AB-1952.3%
    LYS.PALysogene SA-364.7%
    MDG1.DEMedigene AG-268.1%
    MDXH.BRMDxHealth SA-118.9%
    MTPH.LMidatech Pharma PLC-944.6%
    MVIR B.STMedivir AB-2018.2%
    ORY.MCOryzon Genomics SA-26000%
    PHM.MCPharma Mar SA14.9%
    PUR.WAPure Biologics SA-37572.6%
    RENE.LReNeuron Group PLC-1020.8%
    SENZA.STSenzaGen AB-30.9%
    SPRINT.STSprint Bioscience AB-27.8%
    TRX.LTissue Regenix Group PLC-5.8%
    Tickers added to watchlist